Search research articles
Contact Us
Filters
Showing results (161-170 of 340) with videos related to
Page
of 34
Sort By:
Bioinformatics (Oxford, England)
|
February 22, 2019
GlycanAnalyzer: software for automated interpretation of N-glycan profiles after exoglycosidase digestions
Ian Walsh, Terry Nguyen-Khuong, Katherine Wongtrakul-Kish, et al.
Pulmonary Pharmacology & Therapeutics
|
May 18, 2010
Biomarkers in lung oncology
Rafael Rosell, Alain Vergnenegre, Baorui Liu, et al.
Urologic Oncology
|
February 22, 2020
MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer
Carmen Garrigós, Sonia Molina-Pinelo, Ricardo Meléndez, et al.
Molecular Cancer Therapeutics
|
January 14, 2009
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer
Anna Martinez-Cardús, Eva Martinez-Balibrea, Eva Bandrés, et al.
Advances in Experimental Medicine and Biology
|
December 14, 2006
Methylation patterns and chemosensitivity in NSCLC
José Luis Ramírez, M Fernanda Salazar, Jalaj Gupta, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2002
Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors
A Font, J M Sanchez, R Rosell, et al.
The Journal of Biological Chemistry
|
August 25, 2011
Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis
Chelsea L Bueter, Chrono K Lee, Vijay A K Rathinam, et al.
Talanta
|
January 2, 2020
AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine
Wichit Taron, Wassana Jamnongkan, Anchalee Techasen, et al.
Scientific Reports
|
January 9, 2021
A bi-specific lectin from the mushroom Boletopsis grisea and its application in glycoanalytical workflows
Mehul B Ganatra, Vladimir Potapov, Saulius Vainauskas, et al.
British Journal of Cancer
|
April 17, 2008
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
J Souglakos, I Boukovinas, M Taron, et al.
Page
of 34
Search research articles
Search
Showing results (161-170 of 340) with videos related to
Sort By:
Page
of 34
Bioinformatics (Oxford, England)
|
February 22, 2019
GlycanAnalyzer: software for automated interpretation of N-glycan profiles after exoglycosidase digestions
Ian Walsh, Terry Nguyen-Khuong, Katherine Wongtrakul-Kish, et al.
Pulmonary Pharmacology & Therapeutics
|
May 18, 2010
Biomarkers in lung oncology
Rafael Rosell, Alain Vergnenegre, Baorui Liu, et al.
Urologic Oncology
|
February 22, 2020
MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer
Carmen Garrigós, Sonia Molina-Pinelo, Ricardo Meléndez, et al.
Molecular Cancer Therapeutics
|
January 14, 2009
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer
Anna Martinez-Cardús, Eva Martinez-Balibrea, Eva Bandrés, et al.
Advances in Experimental Medicine and Biology
|
December 14, 2006
Methylation patterns and chemosensitivity in NSCLC
José Luis Ramírez, M Fernanda Salazar, Jalaj Gupta, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2002
Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors
A Font, J M Sanchez, R Rosell, et al.
The Journal of Biological Chemistry
|
August 25, 2011
Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis
Chelsea L Bueter, Chrono K Lee, Vijay A K Rathinam, et al.
Talanta
|
January 2, 2020
AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine
Wichit Taron, Wassana Jamnongkan, Anchalee Techasen, et al.
Scientific Reports
|
January 9, 2021
A bi-specific lectin from the mushroom Boletopsis grisea and its application in glycoanalytical workflows
Mehul B Ganatra, Vladimir Potapov, Saulius Vainauskas, et al.
British Journal of Cancer
|
April 17, 2008
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
J Souglakos, I Boukovinas, M Taron, et al.
Page
of 34